Arbitration Board Setting Reimbursement Amounts for Pharmaceutical Innovations in Germany When Price Negations between Payers and Manufacturers Fail: An Empirical Analysis of 5 Years’ Experience
- Resource Type
- Article
- Source
- In
Value in Health December 2016 19(8):1016-1025 - Subject
- Language
- ISSN
- 1098-3015